RTB101 was positive in phase 2b, but phase 3 missed its primary endpoint (clinically symptomatic respiratory infections). ConfidenceDebated Level of evidence●●●●●○ Randomized clinical trial Observed inHuman MissionMap of aging (12 hallmarks) ConceptsDeregulated nutrient sensingRTB101 (dactolisib)mTOR (mTORC1)